<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Institute of Medicine recommended that <z:hpo ids='HP_0000001'>all</z:hpo> patients receive survivorship care plans (SCPs) post-treatment to improve quality of follow-up care </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known regarding how survivors utilize SCPs and the congruency between providers' and survivors' perspectives </plain></SENT>
<SENT sid="2" pm="."><plain>Feedback from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors (in receipt of a personalized/individualized SCP) and <z:hpo ids='HP_0002664'>oncology</z:hpo> providers was obtained via interviews </plain></SENT>
<SENT sid="3" pm="."><plain>Survivors noted SCPs benefits of reduced duplicative procedures and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> worry with the synthesized treatment information </plain></SENT>
<SENT sid="4" pm="."><plain>Providers noted billing/reimbursement and time investiture (for form completion) as potential barriers </plain></SENT>
<SENT sid="5" pm="."><plain>Further investigation of SCPs is warranted regarding utility prior to widespread adoption in follow-up care </plain></SENT>
</text></document>